Ignacio
Bernabeu Morón
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (2)
2022
-
Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study
Endocrine, Vol. 75, Núm. 2, pp. 525-536
2016
-
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
Pituitary, Vol. 19, Núm. 2, pp. 127-137